Related Experiment Video
Updated: Aug 13, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
A Brief Overview of Cancer Vaccines
Alexander J Muller1, Sunil Thomas, George C Prendergast
1From the Lankenau Institute for Medical Research, Wynnewood, PA.
Abstract:
Vaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is damaged, suppressed, or senescent and mainly tolerant of their disease. Thus, vaccine efficacy in a cancer patient will rely upon adjuvant or combination treatments that correct the inflammatory tumor microenvironment and degrade tumoral immunosuppression that dominates patient immunity. This brief overview is aimed at new researchers in cancer immunology seeking an overview of vaccine concepts to eradicate malignancy by provoking a selective immune attack.
Insights
Cancer vaccines aim to clear existing tumors, unlike infectious disease vaccines that prevent illness. Effective cancer vaccines require combination therapies to overcome tumor-induced immune suppression and target altered-self antigens.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Cancer vaccine strategies differ from infectious disease vaccines, focusing on disease clearance rather than prevention.
- Tumor antigens are often "altered-self," eliciting weaker immune responses compared to "foreign" antigens from infectious agents.
- Cancer patients possess compromised immune systems, often tolerant to their malignancy, necessitating strategies to overcome immunosuppression.
Purpose of the Study:
- To survey general vaccine strategies for cancer treatment.
- To explore combination therapy concepts for enhancing vaccine efficacy in eradicating malignancy.
- To provide an overview for new researchers in cancer immunology.
Main Methods:
- Review of current vaccine strategies targeting tumor antigens.
- Discussion of combination therapy approaches.
- Analysis of immune system challenges in cancer patients.
Main Results:
- Vaccine efficacy in cancer is limited by the "altered-self" nature of tumor antigens and the immunosuppressive tumor microenvironment.
- Adjuvant or combination treatments are crucial for correcting inflammation and overcoming tumoral immunosuppression.
- Provoking a selective immune attack is key to eradicating malignancy.
Conclusions:
- Cancer vaccine development must address the unique immunological challenges posed by malignancy.
- Combination therapies are essential to enhance the immune system's ability to target and eliminate cancer cells.
- Future research should focus on overcoming immune tolerance and the immunosuppressive tumor microenvironment for effective cancer immunotherapy.
More Related Videos
12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...